AWM
ACTU

Apollon Wealth Management’s Actuate Therapeutics ACTU Stock Holding History

Apollon Wealth Management’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Buy
+14,013
New +$32.5K ﹤0.01% 1568

Other funds holding ACTU

GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
GRWP
Green Ridge Wealth Planning Montville, New Jersey $238M AUM
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Apollon Wealth Management's ACTU Position: Q2 2026 in Review

Apollon Wealth Management opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 14,013 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #1568 among its holdings.

12 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Apollon Wealth Management held 14,013 shares of Actuate Therapeutics worth $21.4K as of Q2 2026.
  • Actuate Therapeutics was a new Apollon Wealth Management position in Q2 2026.
  • Actuate Therapeutics made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1568 holding.
  • 12 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.